Fennec Pharmaceuticals Inc.
FENC- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001211583
In the last 90 days, Fennec Pharmaceuticals Inc. insiders filed 0 open-market purchases and 5 sales; 105 institutions reported holding it in 13F filings for Q2 2026, worth $175.1M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Fennec Pharmaceuticals Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 84 | 96 | +12 |
| Shares | 13.9M | 15.5M | +1.68M (+12.1%) |
| Value | $129.8M | $119.6M | −$10.1M (−7.8%) |
New holders (20)
Institutions that held Fennec Pharmaceuticals Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| AWM Investment Company, Inc. | 711,869 | $5.48M | 0.53% |
| Apis Capital Advisors, LLC | 204,000 | $1.57M | 0.27% |
| Marshall Wace, LLP | 127,693 | $983.2K | 0.00% |
| Potomac Capital Management, Inc. | 95,100 | $732.3K | 0.61% |
| Trexquant Investment LP | 51,380 | $395.6K | 0.00% |
| Stonepine Capital Management, LLC | 50,000 | $385.0K | 0.30% |
| Qube Research & Technologies Ltd | 44,692 | $344.1K | 0.00% |
| Hillsdale Investment Management Inc. | 44,000 | $338.8K | 0.01% |
| 1492 Capital Management LLC | 28,092 | $216.3K | 0.08% |
| Point72 Asset Management, L.P. | 21,298 | $164.0K | 0.00% |
| Deutsche Bank AG | 17,365 | $133.7K | 0.00% |
| Lazard Asset Management LLC | 13,121 | $101.0K | 0.00% |
| Squarepoint Ops LLC | 13,109 | $100.9K | 0.00% |
| Two Sigma Advisers, LP | 13,000 | $100.1K | 0.00% |
| State of Alaska, Department of Revenue | 1,570 | $12.0K | 0.00% |
| Pinnacle Wealth Planning Services, Inc. | 507 | $3.90K | 0.00% |
| UBS Asset Management Americas Inc | 303 | $2.33K | 0.00% |
| Quaker Wealth Management, LLC | 160 | $1.23K | 0.00% |
| Optima Capital LLC | 63 | $485 | 0.00% |
| True Wealth Design, LLC | 1 | $8 | 0.00% |
Sold out (8)
Institutions that held Fennec Pharmaceuticals Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Tang Capital Management LLC | 334,593 | $3.13M |
| Harbert Fund Advisors, Inc. | 177,815 | $1.66M |
| Simplex Trading, LLC | 21,270 | $199.0K |
| Susquehanna International Group, LLP | 17,023 | $159.3K |
| Franklin Resources Inc | 16,978 | $158.9K |
| SRS Capital Advisors, Inc. | 188 | $1.76K |
| Fifth Third Bancorp | 158 | $1.48K |
| SBI Securities Co., Ltd. | 1 | $9 |